Medtronic Set to Benefit From New Waxing Product Cycles; No Change to Our FVE
Wide-moat Medtronic posted second-quarter results that demonstrated the strength of underlying demand for its products and the firm’s ability to roll out innovative products, despite unexpected speed bumps from hurricane damage to manufacturing facilities. The firm remains on track to meet our full-year projections, and we’re leaving our fair value estimate unchanged. We remain fans of Medtronic’s wide economic moat and saw evidence of it in the second fiscal quarter. Adjusted constant-currency ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.